Siu LL - Search Results

1

Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx.

Siu LL, Czaykowski PM, Tannock IF. Siu LL, et al. J Clin Oncol. 1998 Jul;16(7):2514-21. doi: 10.1200/JCO.1998.16.7.2514. J Clin Oncol. 1998. PMID: 9667272 Clinical Trial.

2

Influence of age on the treatment of limited-stage small-cell lung cancer.

Siu LL, Shepherd FA, Murray N, Feld R, Pater J, Zee B. Siu LL, et al. J Clin Oncol. 1996 Mar;14(3):821-8. doi: 10.1200/JCO.1996.14.3.821. J Clin Oncol. 1996. PMID: 8622030

3

Chemotherapy dose escalation: case unproven.

Siu LL, Tannock IF. Siu LL, et al. J Clin Oncol. 1997 Aug;15(8):2765-8. doi: 10.1200/JCO.1997.15.8.2765. J Clin Oncol. 1997. PMID: 9256117 No abstract available.

4

Use of the somatostatin analogue octreotide acetate in the treatment of encephalopathy associated with carcinoid tumor. Case report.

Siu LL, Chapman W, Moore MJ. Siu LL, et al. Am J Clin Oncol. 1997 Dec;20(6):558-61. doi: 10.1097/00000421-199712000-00004. Am J Clin Oncol. 1997. PMID: 9391539

5

Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation given as a 24-hour continuous infusion weekly times four every 5 weeks.

Siu LL, Oza AM, Eisenhauer EA, Firby PS, Thiessen JJ, Michael M, Wainman N, Manzo J, Feld R, Goldberg RA, Moore MJ. Siu LL, et al. J Clin Oncol. 1998 Mar;16(3):1122-30. doi: 10.1200/JCO.1998.16.3.1122. J Clin Oncol. 1998. PMID: 9508199 Clinical Trial.

6

The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma.

Siu LL, Banerjee D, Khurana RJ, Pan X, Pflueger R, Tannock IF, Moore MJ. Siu LL, et al. Clin Cancer Res. 1998 Mar;4(3):559-65. Clin Cancer Res. 1998. PMID: 9533522

7

A phase II study of temozolomide in advanced untreated pancreatic cancer.

Moore MJ, Feld R, Hedley D, Oza A, Siu LL. Moore MJ, et al. Among authors: siu ll. Invest New Drugs. 1998;16(1):77-9. doi: 10.1023/a:1006043332368. Invest New Drugs. 1998. PMID: 9740547 Clinical Trial.

8

Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors.

Patnaik A, Warner E, Michael M, Egorin MJ, Moore MJ, Siu LL, Fracasso PM, Rivkin S, Kerr I, Litchman M, Oza AM. Patnaik A, et al. Among authors: siu ll. J Clin Oncol. 2000 Nov 1;18(21):3677-89. doi: 10.1200/JCO.2000.18.21.3677. J Clin Oncol. 2000. PMID: 11054441 Clinical Trial.

9

Phase I and pharmacokinetic study of the differentiating agent vesnarinone in combination with gemcitabine in patients with advanced cancer.

Patnaik A, Rowinsky EK, Tammara BK, Hidalgo M, Drengler RL, Garner AM, Siu LL, Hammond LA, Felton SA, Mallikaarjun S, Von Hoff DD, Eckhardt SG. Patnaik A, et al. Among authors: siu ll. J Clin Oncol. 2000 Dec 1;18(23):3974-85. doi: 10.1200/JCO.2000.18.23.3974. J Clin Oncol. 2000. PMID: 11099327 Clinical Trial.

10

Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignancies.

Eckhardt SG, Baker SD, Britten CD, Hidalgo M, Siu L, Hammond LA, Villalona-Calero MA, Felton S, Drengler R, Kuhn JG, Clark GM, Smith SL, MacDonald JR, Smith C, Moczygemba J, Weitman S, Von Hoff DD, Rowinsky EK. Eckhardt SG, et al. J Clin Oncol. 2000 Dec 15;18(24):4086-97. doi: 10.1200/JCO.2000.18.24.4086. J Clin Oncol. 2000. PMID: 11118470

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

441 results

Search Page

Filters